Circ-PRKCI Alleviates Lipopolysaccharide-induced Human Kidney 2 Cell Injury by Regulating miR-106b-5p/GAB1 Axis

Yueli Xiong1, Yang Wang2, Hui Tian1

  • 1Department of Infectious Diseases, Huaihe Hospital of Henan University, Kaifeng, Henan, China; and.

Insights

Circular RNA protein kinase C iota (circ-PRKCI) protects against sepsis-induced acute kidney injury. Overexpressing circ-PRKCI in kidney cells reduced damage by regulating the microRNA-106b-5p/GAB1 pathway.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pathology

Background:

  • Circular RNAs (circRNAs) are crucial in disease pathogenesis.
  • The role of circRNAs in sepsis-induced acute kidney injury (AKI) is understudied.
  • This study investigates circ-PRKCI in lipopolysaccharide (LPS)-induced kidney cell injury.

Purpose of the Study:

  • To explore the function of circ-PRKCI in LPS-mediated human kidney 2 (HK-2) cell injury.
  • To elucidate the molecular mechanism involving circ-PRKCI, microRNA-106b-5p (miR-106b-5p), and growth factor receptor binding 2-associated binding protein 1 (GAB1).

Main Methods:

  • Established an in vitro sepsis model using LPS treatment on HK-2 cells.
  • Quantified circ-PRKCI, miR-106b-5p, and GAB1 levels using quantitative real-time polymerase chain reaction.
  • Assessed cell viability, apoptosis, inflammation, oxidative stress, and protein expression via various assays including Western blot and dual-luciferase reporter assays.

Main Results:

  • Circ-PRKCI levels were reduced in sepsis patients and LPS-treated HK-2 cells.
  • LPS exposure impaired HK-2 cell viability while increasing apoptosis, inflammation, and oxidative stress.
  • Circ-PRKCI overexpression counteracted LPS-induced injury by regulating the miR-106b-5p/GAB1 axis, suggesting circ-PRKCI acts as a sponge for miR-106b-5p to upregulate GAB1.

Conclusions:

  • Circ-PRKCI plays a protective role in LPS-induced HK-2 cell injury.
  • The circ-PRKCI/miR-106b-5p/GAB1 pathway is a potential therapeutic target for sepsis-related AKI.
  • Circ-PRKCI overexpression attenuates kidney cell damage by modulating miR-106b-5p and GAB1 expression.